Recital 27, Regulation (EU) 2025/1489

In forcesince 24 Jul 2025

The risk assessments pursuant to Article 11 of Implementing Regulation (EU) No 844/2012 for ametoctradin and mandipropamid have not yet been finalised by the respective rapporteur Member States and additional time is required to complete the remaining steps in each renewal procedure.

  • celex=32012R0844